The aim of this study was to assess the effect of levothyroxine treatment on blood pressure, lipid profile, highly sensitive CRP (hs- CRP) and arterial stiffness in patients with SCH. Whether SCH is a "laboratory" disease only or it affects blood vessels is a question still in controversy. We do not know yet if levothyroxine therapy will reverse some of the "silent" problems of SCH.